Related Experiment Video
Updated: Aug 30, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
New perspectives in the treatment of tobacco dependence
Abstract:
Tobacco dependance treatment is a long lasting journey that is now approaching the fifty-years landmark. Beginning with lobeline in the late Fifties, and passing through the development of nicotine replacement therapy, the pharmacological therapy of nicotine dependance has now reached a new phase of intense and florishing research. The purpose of this review is to briefly overview the history of tobacco dependence treatments and to lead the reader towards the future, not only in terms of drug therapy but also of new goals like relapse prevention strategies and smoking reduction. Neurobiology of drug addiction mechanisms better understanding has recently unmasked new therapeutical targets and has lead to the development of new drugs. Nicotine vaccine, tetrahydrocannabinoid receptor blockers, partial agonists for the nicotine receptors are now under evaluation. Interference with the liver enzymes metabolising nicotine is another approach who has just reached the testing phase. The article will briefly overview each of this new promising drug treatments.
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Drug Dependence
Drug Abuse and Addiction: Pharmacological Phenomena
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drug Therapy
Antianxiety Medications
Antidepressant Drugs: MAOIs and Other Agents
